Drug-Induced Thrombotic Microangiopathy due to Cumulative Toxicity of Ixazomib

Drug-induced thrombotic microangiopathies (DTMAs) are increasingly being recognized as an important category of thrombotic microangiopathies (TMAs). Cancer therapeutic agents including proteasome inhibitors (PIs) are among the most common medications reported to cause DTMA. PIs could cause DTMA eith...

Descripción completa

Detalles Bibliográficos
Autores principales: Atallah-Yunes, Suheil Albert, Soe, Myat Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6051099/
https://www.ncbi.nlm.nih.gov/pubmed/30057831
http://dx.doi.org/10.1155/2018/7063145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6051099/
https://www.ncbi.nlm.nih.gov/pubmed/30057831
http://dx.doi.org/10.1155/2018/7063145

Ejemplares similares